Multifocality as independent prognostic factor in papillary thyroid cancer - A multivariate analysis

被引:1
作者
Markovic, Ivan [1 ,2 ]
Goran, Merima [1 ]
Besic, Nikola [3 ]
Buta, Marko [1 ,2 ]
Djurisic, Igor [1 ]
Stojiljkovic, Dejan [1 ]
Zegarac, Milan [1 ,2 ]
Pupic, Gordana [4 ]
Inic, Zorka [1 ]
Dzodic, Radan [1 ,2 ]
机构
[1] Inst Oncol & Radiol Serbia, Surg Oncol Clin, Belgrade, Serbia
[2] Univ Belgrade, Sch Med, Belgrade, Serbia
[3] Inst Oncol Ljubljana, Ljubljana, Slovenia
[4] Inst Oncol & Radiol Serbia, Dept Pathol, Belgrade, Serbia
来源
JOURNAL OF BUON | 2018年 / 23卷 / 04期
关键词
multifocality; papillary thyroid carcinoma; relapse; survival; TUMOR MULTIFOCALITY; CARCINOMA; INSTITUTION; NODULES; IMPACT;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The incidence of multifocality of papillary thyroid carcinoma (PTC) ranges from 18 to 87.5% The mechanisms of multifocal spreading, correlation with tumor size, histology variants of PTC, lymph node metastases, and prognostic impact remains unclear. The purpose of this study was to clarify the prognostic significance of multifocality on relapse and survival rates of patients with PTC by analyzing the correlation of multifocality with patient age, gender, tumor size, histological variants of PTC, presence of lymph node metastases and extent of surgery. Methods: 153 patients with PTC were included in this study. Patients with pT4 tumors or initially distant metastases were excluded from study. Total thyroidectomy was done in all 153 patients. Central and level III and IV lateral neck lymph node dissection was done in 76.5% of the patients, followed by modified radical neck dissection if positive. Results: Multifocality was found in 43 (28%) whole thyroid gland specimens, and was significantly more frequent in patients older than 45 years and in tumors greater than 4 cm in diameter (p<0.01). Presence of multifocality didn't significantly correlate with gender, histology variants of PTC or lymph node metastases. In a median follow up of 84 months locoregional relapse occurred in 8.4% and 1.3% of the patients, while 7.2% patients died due to PTC. The incidence of relapse was significantly higher (p<0.01), and relapse free interval and survival were significantly shorter (p=0.0095, p=0.0004, respectively) in patients with multifocal PTC. Cox multivariate regression analysis showed that multifocality was independent prognostic factor for both disease-free interval (DFI) and cancer-specific survival (CSS) of patients with PTC. Conclusion: Due to high incidence of multifocality and potential prognostic impact, total thyroidectomy should be advocated in all patients with PTC, aiming to reduce relapse rate and improve DFI and CSS.
引用
收藏
页码:1049 / 1054
页数:6
相关论文
共 50 条
  • [41] p53 is an independent prognostic factor for survival in thyroid cancer
    Bachmann, Kai
    Pawliska, Denise
    Kaifi, Jussuf
    Schurr, Paulus
    Zoerb, Jennifer
    Mann, Oliver
    Kahl, Hans J.
    Izbicki, Jakob R.
    Strate, Tim
    ANTICANCER RESEARCH, 2007, 27 (6B) : 3993 - 3997
  • [42] The Role of Vitamin D as a Prognostic Marker in Papillary Thyroid Cancer
    Bains, Ashank
    Mur, Taha
    Wallace, Nathan
    Noordzij, Jacob Pieter
    CANCERS, 2021, 13 (14)
  • [43] The Association of the BRAFV600E Mutation With Prognostic Factors and Poor Clinical Outcome in Papillary Thyroid Cancer
    Kim, Tae Hyuk
    Park, Young Joo
    Lim, Jung Ah
    Ahn, Hwa Young
    Lee, Eun Kyung
    Lee, You Jin
    Kim, Kyung Won
    Hahn, Seo Kyung
    Youn, Yeo Kyu
    Kim, Kwang Hyun
    Cho, Bo Youn
    Park, Do Joon
    CANCER, 2012, 118 (07) : 1764 - 1773
  • [44] Pathological multifocality is not a prognosis factor of papillary thyroid carcinoma: a single-center, retrospective study
    Yoko Omi
    Kento Haniu
    Hidenori Kamio
    Mikiko Fujimoto
    Yusaku Yoshida
    Kiyomi Horiuchi
    Takahiro Okamoto
    World Journal of Surgical Oncology, 20
  • [45] Pathological multifocality is not a prognosis factor of papillary thyroid carcinoma: a single-center, retrospective study
    Omi, Yoko
    Haniu, Kento
    Kamio, Hidenori
    Fujimoto, Mikiko
    Yoshida, Yusaku
    Horiuchi, Kiyomi
    Okamoto, Takahiro
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [46] Metabolite analysis-aided diagnosis of papillary thyroid cancer
    Chen, Jian
    Hu, Qingyuan
    Hou, Hongwei
    Wang, Shuo
    Zhang, Yunfei
    Luo, Yanbo
    Chen, Huan
    Deng, Huimin
    Zhu, Hongfu
    Zhang, Lirong
    Liu, Hansong
    Wang, An
    Liu, Yong
    ENDOCRINE-RELATED CANCER, 2019, 26 (12) : 829 - 841
  • [47] Prognostic Value of Tumor Multifocality in Pediatric Papillary Thyroid Carcinoma: A Real-Life Multicentric Study
    Xu, Yangmengyuan
    Shi, Lei
    Wu, Jie
    Li, Huilan
    Wang, Yu
    Liu, Bin
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2023, 169 (06) : 1606 - 1614
  • [48] Is Male Gender a Prognostic Factor for Papillary Thyroid Microcarcinoma?
    Yi Ho Lee
    Yu Mi Lee
    Tae Yon Sung
    Jong Ho Yoon
    Dong Eun Song
    Tae Yong Kim
    Jung Hwan Baek
    Jin Suk Ryu
    Ki Wook Chung
    Suck Joon Hong
    Annals of Surgical Oncology, 2017, 24 : 1958 - 1964
  • [49] Is Male Gender a Prognostic Factor for Papillary Thyroid Microcarcinoma?
    Lee, Yi Ho
    Lee, Yu Mi
    Sung, Tae Yon
    Yoon, Jong Ho
    Song, Dong Eun
    Kim, Tae Yong
    Baek, Jung Hwan
    Ryu, Jin Suk
    Chung, Ki Wook
    Hong, Suck Joon
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (07) : 1958 - 1964
  • [50] Is Body Mass Index a prognostic factor of survival in colonic cancer? A multivariate analysis
    Garcia-Oria Serrano, Miguel Juan
    Armengol Carrasco, Manel
    Caballero Millan, Aranzazu
    Ching, Christine D.
    Codina Cazador, Antoni
    CIRUGIA ESPANOLA, 2011, 89 (03): : 152 - 158